March 22, 2012: Health Canada Public Advisory - Sandoz Canada recalling partial lot of 2mg/mL (1mL) Morphine Sulfate Injection
Health Canada is advising Canadians that Sandoz Canada Inc. will be voluntarily recalling a portion of one lot of 2mg/mL (1mL) Morphine Sulfate Injection (Lot CC2824 exp. 2014–12) from the Canadian market. The recall applies to all products that has been distributed to healthcare providers.The recall is in light of a report from a Toronto hospital that found one box labelled as morphine ampoules (vials) which incorrectly contained ampoules of isoproterenol. Read more ...
